Bipolar Disorder
|
0.740 |
Biomarker
|
disease |
PSYGENET |
Recently, associations were found between variations in the S100B gene and schizophrenia as well as bipolar affective disorder.
|
21112154 |
2011 |
Bipolar Disorder
|
0.740 |
Biomarker
|
disease |
PSYGENET |
Higher mean serum S100B levels were associated with the risk G allele of rs3788266 in BPAD cases (P = 0.0001), unaffected relatives of BPAD cases (P < 0.0001) and unrelated controls (P < 0.0001).
|
21714070 |
2011 |
Bipolar Disorder
|
0.740 |
Biomarker
|
disease |
PSYGENET |
These genes include GRM7, previously associated to major depression disorder and bipolar disorder, SLC6A13, in anxiety disorders, and S100B, SSTR5 and COMT in schizophrenia.
|
20398908 |
2010 |
Bipolar Disorder
|
0.740 |
Biomarker
|
disease |
PSYGENET |
Fine-mapping analyses of 21q22 have previously identified transient receptor potential gene melastatin 2 (TRPM2), which is 2 Mb upstream of S100B, as a possible BPAD susceptibility gene at 21q22.
|
17525977 |
2007 |
Bipolar Disorder
|
0.740 |
Biomarker
|
disease |
CTD_human |
Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia.
|
16476148 |
2006 |
Bipolar Disorder
|
0.740 |
Biomarker
|
disease |
CTD_human |
Our findings reinforce the role of astroglial cells in the pathogenesis of bipolar disorder and S100B protein as a marker of bipolar mania.
|
15581912 |
2004 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens.
|
20962330 |
2010 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Significant differences in the subgroup depression (first-episode and recurrent depression) were also shown in 3 genotypes of S100B rs9722 and rs11911834 in patients and control subjects (P < 0.05).
|
19497163 |
2009 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Although it may be open for discussion whether the neuroprotective effects of ONO-2506 are exclusively due to its inhibition of S100B synthesis, the latter action of ONO-2506 warrants studies of the effects of this drug in the pathobiology of depression.
|
16797859 |
2006 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
S100 beta, a calcium binding brain protein expressed by astrocytes, has been shown to be involved in higher neural processes, including hippocampal-dependent behavioral traits and hippocampal neuronal long-term potentiation (LTP) and depression (LTD), neurophysiological phenomena that may be involved in exploring, learning and remembering novel stimuli.
|
8804639 |
1996 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
S100 beta, a calcium binding astrocytic brain protein, influences hippocampal long-term potentiation (LTP) and depression (LTD), synaptic processes suggested to play role in spatial (contextual) learning and memory.
|
8840925 |
1996 |
Myocardial Infarction
|
0.530 |
Biomarker
|
disease |
CTD_human |
We now extend this work by showing that S100beta is induced in hearts of human subjects after myocardial infarction.
|
9788975 |
1998 |
Hematoma
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
The single measurement of serum S100B at 6 h after ICH induction was significantly correlated with brain edema formation and the maximal extent of the hematoma volumes.
|
19027832 |
2009 |
Brain Edema
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
The single measurement of serum S100B at 6 h after ICH induction was significantly correlated with brain edema formation and the maximal extent of the hematoma volumes.
|
19027832 |
2009 |
Depression, Bipolar
|
0.500 |
Biomarker
|
disease |
CTD_human |
Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia.
|
16476148 |
2006 |
Manic Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia.
|
16476148 |
2006 |
Depression, Bipolar
|
0.500 |
Biomarker
|
disease |
CTD_human |
Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain.
|
15581912 |
2004 |
Manic Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain.
|
15581912 |
2004 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
The receptor for advanced glycation end products (RAGE) is the main receptor for S100B, an astrogial proinflammatory mediator that has been suggested to be involved in the pathophysiology of schizophrenia.
|
22146151 |
2012 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
These results implicate a role for S100B gene polymorphisms in the cognitive functions of schizophrenia patients and encourage further investigation into spatial disability as an endophenotype of schizophrenia.
|
21070816 |
2011 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens.
|
20962330 |
2010 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
These genes include GRM7, previously associated to major depression disorder and bipolar disorder, SLC6A13, in anxiety disorders, and S100B, SSTR5 and COMT in schizophrenia.
|
20398908 |
2010 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Significant differences in the subgroup depression (first-episode and recurrent depression) were also shown in 3 genotypes of S100B rs9722 and rs11911834 in patients and control subjects (P < 0.05).
|
19497163 |
2009 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Although it may be open for discussion whether the neuroprotective effects of ONO-2506 are exclusively due to its inhibition of S100B synthesis, the latter action of ONO-2506 warrants studies of the effects of this drug in the pathobiology of depression.
|
16797859 |
2006 |
Down Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
Harm avoidance, anxiety, and response to novelty in the adolescent S-100beta transgenic mouse: role of serotonin and relevance to Down syndrome.
|
12888777 |
2003 |